Evaluation of a Simplified Risk Stratification Twice-Daily Aspirin Protocol for Venous Thromboembolism Prophylaxis After Total Joint Replacement.
Candy NgSarah ZavalaElissa S DavisWilliam H AdamsMichael S PinzurPublished in: Journal of pharmacy practice (2018)
A simplified risk-stratified protocol used to choose patients for aspirin 325 mg twice-daily therapy is safe and effective in patients undergoing TJR, and SSI and return to OR rates may be lower when compared to universal warfarin therapy.
Keyphrases
- venous thromboembolism
- patients undergoing
- low dose
- end stage renal disease
- randomized controlled trial
- direct oral anticoagulants
- newly diagnosed
- ejection fraction
- chronic kidney disease
- cardiovascular events
- peritoneal dialysis
- stem cells
- cardiovascular disease
- coronary artery disease
- surgical site infection
- percutaneous coronary intervention
- bone marrow
- breast cancer risk